Thread: FDA Clears First Drug for Parkinson's Dyskinesia - Medscape
View Single Post
Old 08-26-2017, 02:10 AM
NewsBot NewsBot is offline
News Gatherer
Community Support Team
  
Join Date: Dec 2007
Posts: 65,355
15 yr Member
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
Post FDA Clears First Drug for Parkinson's Dyskinesia - Medscape

Medscape

FDA Clears First Drug for Parkinson's Dyskinesia
Medscape
The US Food and Drug Administration (FDA) has approved amantadine extended-release capsules (Gocovri, Adamas Pharmaceuticals Inc) for treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without ...
Adamas wins its first FDA OK, setting up market launch for a reformulated Parkinson's drugEndpoints News
Adamas Pharma secures approval for Parkinson's dyskinesia drugReuters
Adamas Pharma shares soar on Parkinson's dyskinesia drug approvalMarketWatch
Benzinga -STAT -Neurology Advisor -GlobeNewswire
all 54 news articles »


More...
NewsBot is offline   Reply With QuoteReply With Quote